{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:46:40Z","timestamp":1793339200364,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajkd.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1053\/j.ajkd.2023.12.020","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T01:52:24Z","timestamp":1709085144000},"page":"179-194.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Plasma Levels of Polyunsaturated Fatty Acids and Adverse Kidney Outcomes"],"prefix":"10.1053","volume":"84","author":[{"given":"Hee Byung","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Su","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ik","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Tak","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-5635","authenticated-orcid":false,"given":"Seung Hyeok","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2023.12.020_bib1","series-title":"Chronic Kidney Disease in England: The Human and Financial Cost","author":"Kerr","year":"2012"},{"issue":"8","key":"10.1053\/j.ajkd.2023.12.020_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038423","article-title":"Prevalence of chronic kidney disease in adults in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016","volume":"10","author":"Hounkpatin","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.020_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semnephrol.2016.05.008","article-title":"The economic burden of chronic kidney disease and end-stage renal disease","volume":"36","author":"Wang","year":"2016","journal-title":"Semin Nephrol"},{"issue":"9889","key":"10.1053\/j.ajkd.2023.12.020_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"issue":"14","key":"10.1053\/j.ajkd.2023.12.020_bib5","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1 suppl","key":"10.1053\/j.ajkd.2023.12.020_bib6","first-page":"18s","article-title":"Functional roles of fatty acids and their effects on human health","volume":"39","author":"Calder","year":"2015","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"9","key":"10.1053\/j.ajkd.2023.12.020_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/biomedicines8090306","article-title":"The anti-inflammatory and antioxidant properties of n-3 PUFAs: their role in cardiovascular protection","volume":"8","author":"Oppedisano","year":"2020","journal-title":"Biomedicines"},{"issue":"7","key":"10.1053\/j.ajkd.2023.12.020_bib8","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3390\/nu13072421","article-title":"Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: an update for 2021","volume":"13","author":"Djuricic","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.020_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n-3 fatty acids and prevention of cardiovascular disease and cancer","volume":"380","author":"Manson","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1053\/j.ajkd.2023.12.020_bib10","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"issue":"25","key":"10.1053\/j.ajkd.2023.12.020_bib11","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9177","key":"10.1053\/j.ajkd.2023.12.020_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial","volume":"354","year":"1999","journal-title":"Lancet"},{"issue":"9645","key":"10.1053\/j.ajkd.2023.12.020_bib13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ajkd.2023.12.020_bib14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3945\/ajcn.111.030114","article-title":"Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial","volume":"95","author":"Bjermo","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.ajkd.2023.12.020_bib15","doi-asserted-by":"crossref","first-page":"i1246","DOI":"10.1136\/bmj.i1246","article-title":"Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)","volume":"353","author":"Ramsden","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.020_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1373\/clinchem.2007.095521","article-title":"Plasma polyunsaturated fatty acids and the decline of renal function","volume":"54","author":"Lauretani","year":"2008","journal-title":"Clin Chem"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.020_bib17","first-page":"303","article-title":"Association between serum long-chain n-3 and n-6 polyunsaturated fatty acid profiles and glomerular filtration rate assessed by serum creatinine and cystatin C levels in Japanese community-dwellers","volume":"25","author":"Higashiyama","year":"2015","journal-title":"J\u00a0Epidemiol"},{"issue":"19","key":"10.1053\/j.ajkd.2023.12.020_bib18","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1001\/jama.2019.17380","article-title":"Effect of vitamin D and omega-3 fatty acid supplementation on kidney function in patients with type 2 diabetes: a randomized clinical trial","volume":"322","author":"De Boer","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.020_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.020_bib20","first-page":"4","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"19","key":"10.1053\/j.ajkd.2023.12.020_bib21","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2023.12.020_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.atherosclerosis.2016.03.037","article-title":"Reverse association of omega-3\/omega-6 polyunsaturated fatty acids ratios with carotid atherosclerosis in patients on hemodialysis","volume":"249","author":"Umemoto","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.ajkd.2023.12.020_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation","volume":"132","author":"Innes","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.020_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1017\/S0007114522003282","article-title":"Estimation and predictors of the omega-3 Index in the UK Biobank","volume":"130","author":"Schuchardt","year":"2023","journal-title":"Br J Nutr"},{"issue":"10","key":"10.1053\/j.ajkd.2023.12.020_bib25","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3390\/nu11102279","article-title":"A\u00a0novel anti-inflammatory role of omega-3 PUFAs in prevention and treatment of atherosclerosis and vascular cognitive impairment and dementia","volume":"11","author":"Simonetto","year":"2019","journal-title":"Nutrients"},{"key":"10.1053\/j.ajkd.2023.12.020_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.atherosclerosis.2016.04.026","article-title":"Eicosapentaenoic acid to arachidonic acid (EPA\/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease","volume":"250","author":"Nagahara","year":"2016","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1053\/j.ajkd.2023.12.020_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/cyto.2002.2007","article-title":"In\u00a0vitro effects of eicosanoids derived from different 20-carbon fatty acids on production of monocyte-derived cytokines in human whole blood cultures","volume":"20","author":"Miles","year":"2002","journal-title":"Cytokine"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.020_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/bbrc.2001.6155","article-title":"Endogenous anti-inflammatory mediators from arachidonate in human neutrophils","volume":"290","author":"Vachier","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1053\/j.ajkd.2023.12.020_bib29","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.4049\/jimmunol.168.10.5260","article-title":"Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis","volume":"168","author":"Gewirtz","year":"2002","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1053\/j.ajkd.2023.12.020_bib30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1053\/j.ajkd.2023.12.020_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3349\/ymj.2012.53.6.1165","article-title":"Gamma linolenic acid exerts anti-inflammatory and anti-fibrotic effects in diabetic nephropathy","volume":"53","author":"Kim","year":"2012","journal-title":"Yonsei Med J"},{"issue":"9","key":"10.1053\/j.ajkd.2023.12.020_bib32","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1017\/S0007114510005040","article-title":"Consumption of long-chain n-3 PUFA, alpha-linolenic acid and fish is associated with the prevalence of chronic kidney disease","volume":"105","author":"Gopinath","year":"2011","journal-title":"Br J Nutr"},{"issue":"18","key":"10.1053\/j.ajkd.2023.12.020_bib33","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM199411033311804","article-title":"A\u00a0controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group","volume":"331","author":"Donadio","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2023.12.020_bib34","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1681\/ASN.V1081772","article-title":"The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group","volume":"10","author":"Donadio","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.020_bib35","first-page":"128","article-title":"Treatment of IgA nephropathy with eicosapentanoic acid (EPA): a two-year prospective trial","volume":"31","author":"Bennett","year":"1989","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.020_bib36","first-page":"183","article-title":"Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study","volume":"41","author":"Pettersson","year":"1994","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.020_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ndt\/5.4.241","article-title":"The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis","volume":"5","author":"Cheng","year":"1990","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.020_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ndt\/gfn454","article-title":"Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial","volume":"24","author":"Ferraro","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"3 suppl","key":"10.1053\/j.ajkd.2023.12.020_bib39","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","year":"2021","journal-title":"Kid Int Suppl"},{"issue":"6","key":"10.1053\/j.ajkd.2023.12.020_bib40","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2215\/CJN.02300606","article-title":"Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent","volume":"1","author":"Hogg","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2023.12.020_bib41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","article-title":"Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations","volume":"17","author":"Noels","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.020_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"issue":"5","key":"10.1053\/j.ajkd.2023.12.020_bib43","first-page":"609","article-title":"Serum lipid profile and plasma fatty acid composition in hemodialysis patients\u2014comparison with chronic kidney disease patients","volume":"22","author":"Nakamura","year":"2008","journal-title":"In\u00a0Vivo"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.020_bib44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/0886022X.2017.1295870","article-title":"Disorders of serum omega-3 fatty acid composition in dialyzed patients, and their associations with fat mass","volume":"39","author":"Sikorska-Wisniewska","year":"2017","journal-title":"Ren Fail"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.020_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000012777","article-title":"Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids","volume":"43","author":"Simopoulos","year":"1999","journal-title":"Ann Nutr Metab"},{"key":"10.1053\/j.ajkd.2023.12.020_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000073796","article-title":"The Japan Society for Lipid Nutrition recommends to reduce the intake of linoleic acid: a review and critique of the scientific evidence","volume":"92","author":"Hamazaki","year":"2003","journal-title":"World Rev Nutr Diet"},{"key":"10.1053\/j.ajkd.2023.12.020_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000327800","article-title":"Update of French nutritional recommendations for fatty acids","volume":"102","author":"Legrand","year":"2011","journal-title":"World Rev Nutr Diet"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.020_bib48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000510","article-title":"Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association","volume":"136","author":"Sacks","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1053\/j.ajkd.2023.12.020_bib49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.plefa.2007.05.003","article-title":"Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans","volume":"76","author":"Rise","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.020_bib50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/aje\/kwi213","article-title":"Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma","volume":"162","author":"Baylin","year":"2005","journal-title":"Am J Epidemiol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862400622X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862400622X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T10:28:39Z","timestamp":1721384919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263862400622X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S027263862400622X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.12.020","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Levels of Polyunsaturated Fatty Acids and Adverse Kidney Outcomes","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}